Fidelity Fidelity SPDR Advertisement
Home > Boards > Free Zone > Big Board Trading - Technical > *SCALPSWINGSTRADDLE* ($$$)

Pharmacyclics pullback a buying opportunity, says Credit Suisse

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
madrose1 Member Profile
Member Level 
Followed By 300
Posts 47,229
Boards Moderated 10
Alias Born 04/07/01
160x600 placeholder
U.S. Stocks: Futures Climb Ahead Of ISM Data
U.S. stocks were poised to kick off September on a high note on Tuesday, with futures moving broadly up ahead of data expected to show healthy U.S. factory activity in August.
Top Equities Stories Of The Day
Apple Investigating Reports of iCloud Vulnerabilities
US Court Dismisses Aluminum Antitrust Cases
J.P. Morgan Working With Law Enforcement on Cyber Attack -- 3rd Update
Stocks Drift Between Gains, Losses
European Investors Eye Ukraine, ECB
Ex-LPL Broker Ordered to Pay Nearly $2 Million
U.S. Hot Stocks: Hot Stocks to Watch
ADR Shares End Lower; Oi Shares Active
madrose1 Member Level  Monday, 03/25/13 08:37:55 AM
Re: None
Post # of 643849 
Pharmacyclics pullback a buying opportunity, says Credit Suisse
Credit Suisse would use the pullback in Pharmacyclics as a buying opportunity given the multi-billion dollar potential of ibrutinib. Shares are Outperform rated with a $90 price target

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist